ABL vs. ML, PAX, BSIG, BRDG, FDUS, NOAH, VINP, ALTI, BBDC, and DHIL
Should you be buying Abacus Life stock or one of its competitors? The main competitors of Abacus Life include MoneyLion (ML), Patria Investments (PAX), BrightSphere Investment Group (BSIG), Bridge Investment Group (BRDG), Fidus Investment (FDUS), Noah (NOAH), Vinci Partners Investments (VINP), AlTi Global (ALTI), Barings BDC (BBDC), and Diamond Hill Investment Group (DHIL).
Abacus Life (NASDAQ:ABL) and MoneyLion (NYSE:ML) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.
Abacus Life has a net margin of 0.11% compared to MoneyLion's net margin of -6.42%. Abacus Life's return on equity of 4.96% beat MoneyLion's return on equity.
Abacus Life has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Comparatively, MoneyLion has a beta of 2.68, meaning that its stock price is 168% more volatile than the S&P 500.
31.4% of MoneyLion shares are held by institutional investors. 47.0% of Abacus Life shares are held by company insiders. Comparatively, 14.1% of MoneyLion shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
In the previous week, MoneyLion had 6 more articles in the media than Abacus Life. MarketBeat recorded 11 mentions for MoneyLion and 5 mentions for Abacus Life. MoneyLion's average media sentiment score of 0.49 beat Abacus Life's score of 0.35 indicating that MoneyLion is being referred to more favorably in the news media.
Abacus Life has higher earnings, but lower revenue than MoneyLion. MoneyLion is trading at a lower price-to-earnings ratio than Abacus Life, indicating that it is currently the more affordable of the two stocks.
MoneyLion has a consensus price target of $78.60, indicating a potential downside of 7.28%. Given MoneyLion's higher probable upside, analysts plainly believe MoneyLion is more favorable than Abacus Life.
MoneyLion received 12 more outperform votes than Abacus Life when rated by MarketBeat users. Likewise, 70.59% of users gave MoneyLion an outperform vote while only 0.00% of users gave Abacus Life an outperform vote.
Summary
MoneyLion beats Abacus Life on 9 of the 17 factors compared between the two stocks.
Get Abacus Life News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abacus Life Competitors List
Related Companies and Tools
